Vaccine maker Serum Institute of India said the doses had expired due to falling demand.
Indian vaccine maker Serum Institute of India has said it had to dump 100 million doses of their Covid-19 vaccine after they expired.
SII, the world's largest vaccine maker, has been making the local version of AstraZeneca's Vaxzevria jab.India has administered over two billion doses of Covid-19 vaccines. More than 70% of the Indian population has taken at least two doses, according to the federal health ministry. In July, free booster doses - or precaution doses as the government calls it - were provided to all adults for 75 days to mark 75 years of India's independence."The booster vaccines have no demand as people now seem fed up with Covid," Mr PoonawalaAccording to Mr Poonawala, the SII had around 100 million doses of Covishield in stock. The vaccines - which have a shelf life of nine months - expired in September this year.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
We tried Sephora's best selling foundation - and it wasn't what we were expectingNow available to shop in the UK, this viral skin tint is Sephora's best seller. Here, see our honest review of Ilia Super Serum Skin Tint
Read more »
CDC panel votes to add COVID shots to immunization scheduleAdvisers to the CDC on Thursday unanimously voted to add COVID-19 vaccines to the 2023 schedule of childhood and adult immunizations. States and localities still have the final say on whether to require vaccinations for school-age children.
Read more »
FDA, CDC sign off on Novavax Covid-19 vaccine as a first booster shot | CNNThe US Food and Drug Administration authorized Novavax’s Covid-19 vaccine for use as a first booster dose among adults 18 and older, at least six months after completing a primary Covid-19 vaccine series.
Read more »
US clears Novavax COVID booster doseThe Food and Drug Administration has authorized a booster dose of the COVID-19 vaccine made by Novavax.
Read more »